Endoscopic considerations in gastroesophageal reflux disease

W. Scott Melvin, Jeffrey L. Eakin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Gastroesophageal reflux disease affects approximately 50 million Americans and some studies estimate the prevalence approaches 20 % of the population in many Western countries. Approximately 50 % of the U.S. population experiences gastroesophageal reflux disease astroesophageal reflux disease-related symptoms once a month, and one in ten Americans experience symptoms of heartburn and bloating every day. This tremendously prevalent condition has had and will continue to have a significant economic impact on the Unites States and other developed Western countries. In view of that, numerous countries expend a considerable amount of resources on direct and indirect costs attributable to the prevention and treatment of reflux disease. Gastroesophageal reflux disease has a substantial impact on clinical and financial welfare since patients suffering from this disorder generally report a diminished health-related quality of life (HRQL), reduced work productivity, and depressed psychological health.

Original languageEnglish (US)
Title of host publicationPrinciples of Flexible Endoscopy for Surgeons
PublisherSpringer New York
Pages157-166
Number of pages10
ISBN (Electronic)9781461463306
ISBN (Print)1461463297, 9781461463290
DOIs
StatePublished - Oct 1 2013
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Endoscopic considerations in gastroesophageal reflux disease'. Together they form a unique fingerprint.

  • Cite this

    Melvin, W. S., & Eakin, J. L. (2013). Endoscopic considerations in gastroesophageal reflux disease. In Principles of Flexible Endoscopy for Surgeons (pp. 157-166). Springer New York. https://doi.org/10.1007/978-1-4614-6330-6_14